![]() You may give other people a serious infection, or get a serious infection from them. Do not re-use or share needles with other people.Do not remove SOLIQUA 100/33 from the pen with a syringe.Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged. Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites.If you see small particles, return it to your pharmacy for replacement. Only use SOLIQUA 100/33 that is clear and colorless to almost colorless.Do not take SOLIQUA 100/33 with other GLP-1 receptor agonists. Do not take more than 60 units of SOLIQUA 100/33 each day.Check the pen label each time you inject to make sure you are using the correct medicine.Do not change your dose without first talking to your healthcare provider. ![]() Before using SOLIQUA 100/33, talk to your healthcare provider about low blood sugar and how to manage it. SOLIQUA 100/33 may affect the way some medicines work. ![]() Tell your healthcare provider about all the medicines you take, including all prescription and over-the-counter medicines, vitamins, and herbal supplements. It is not known if SOLIQUA 100/33 will harm your unborn baby or pass into your breast milk. are pregnant or breastfeeding or plan to become pregnant or to breastfeed.have had an allergic reaction to a GLP-1 receptor agonist.are taking certain medicines called glucagon-like peptide 1 receptor agonists (GLP-1 receptor agonists).have severe problems with your stomach, such as slowed emptying of your stomach or problems digesting food.If you have heart failure, it may get worse while you take thiazolidinediones (TZDs). have heart failure or other heart problems. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |